摘要
Coronavirus Disease 2019(COVID-19)has caused a global outbreak and become a major public health issue.On January 20,2020,the announcement of National Health Commission(No.1 of 2020)included COVID-19 as a category B infectious disease in Law of the People's Republic of China on prevention and control of Infectious Diseases,and took preventing and controlling measures like those of category A infectious diseases^([1]).Tumor patients are more susceptible to infection because of their vulnerable nutritional state and systemic immunosuppressive state caused by antitumor treatments,such as radiotherapy,chemotherapy and surgery^([2]).Cancer patients had an estimated 2-fold increased risk of COVID-19 than the general population according to the Report of the WHO-China Joint Mission on COVID-19^([3]);The incidence rate of COVID-19 in cancer patients in Wuhan is 0.79%,while the general population is 0.37%in the same period^([4]).And the COVID-19 cancer patients were with higher risk to become severe condition and worse prognosis,especially in those patients who received chemotherapy or surgery recently,than those without cancer^([5-6]).In addition,the inconvenience for patients going out to see doctors also leads to the delay of diagnosis and treatment.As a result,under the current severe situation,scientific and effective management measures and reasonable responsive strategies are urgently needed to minimize the impact of the epidemic on tumor patients^([7-9]).Especially recently,the outbreak continues to spread in many countries around the world.World Health Organization(WHO)believes the COVID-19 epidemic has the characteristics of a pandemic,calling on all countries to take urgent and active action.Under such circumstances,experts organized by Classical Traditional Chinese Medicine Prescription for Cancer Treatment and Research Committee of World Federation of Chinese Medicine Societies,discussed and formed"Expert Consensus on Integrated Traditional and Western Medicine Prevention and Rehabilitation During the Epidemics of Coronavirus Disease 2019",according to national prevention and treatment experience of COVID-19,especially in Wuhan.This consensus aims to provide a model for TCM experts around the world to guide tumor patients to respond reasonably and safely through COVID-19.Thoroughly taking advantages of integrated Chinese and Western medicine in diagnosis and treatment can minimize the adverse effects of the epidemic on patients with malignant tumors.
作者
FENG Li
WANG Yu-guang
HU Zuo-wei
FAN Heng
ZHANG Ying-wen
YANG Chen-guang
TANG Dongxin
LU Wei-dong
LIN Qing-zhong
WANG Xiao-hui
YIN Yu-kun
LIU Li-xing
冯利;王玉光;胡作为;范恒;张莹雯;杨晨光;唐东昕;陆卫东;林庆钟;王晓辉;殷玉琨;刘丽星(Department of Chinese Medicine,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,100021,China;Department of Respiratory Disease,Beijing Hospital of Traditional Chinese Medicine,Capital Medical University;Department of Oncology,Wuhan No.1 Hospital;Department of Traditional Chinese Medicine,Union Hospital,Tongji Medical College of Huazhong University of Science and Technology;Department of Chinese with Western Medicine,Zhongnan Hospital of Wuhan University,Wuhan,China;Department of Oncology,Shanxi Hospital of Traditional Chinese Medicine;Department of Oncology,The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine;Center for Integrative Therapies,Dana-Farber Cancer Institute,Harvard Medical School;Central Taiwan University of Science and Technology,Department of Traditional Chinese Medicine,Fengyuan Hospital of Health Promotion Administration of Taiwan,China;French Federation of Digestive Cancer)
基金
The Disciplinary Construction Project of Peking Union Medical College Cancer Disciplinary Construction of Integration of Traditional Chinese and Western Medicine grant number 201920100302。